Research on Chimeric Artificial Nucleic Acid(CANA) Based Drug Development
Developing Innovative Therapeutics Based on the Highly Active Catalytic RNA Cleavage Function of Chimeric Artificial Nucleic Acids
2026/4/1 - 2027/3/31
Specially Appointed ProfessorTakehiko Wada
Currently under preparation